About Pricing FAQs Providers Trials Blog

Login Get started

Finding studies

Your health journey, clearly organized.

Questions? [email protected]

Product

How it works
Pricing
For Providers
Trials

Company

About
Blog
FAQ

Legal

Privacy Policy
Terms of Service

© 2026 Clareo Health. All rights reserved.

Safety and Efficacy Study of Lithium in Bipolar Disorder

NCT00422331·1 site·ClinicalTrials.gov

What this study is about

Take this into the appointment.

Saves the questions and what to expect into your notes, next to the visit they belong to.

Keep this study

Lead

JDS Pharmaceuticals

Age

18–65

Sex

ALL

Healthy volunteers

Not accepted

You may be eligible if

Diagnosis of Bipolar 1 Disorder;
Hospitalized or in the process of being hospitalized for a manic or mixed episode

You may not be if

History of rapid cycling;
History of hypersensitivity or adverse reaction to lithium

The record

StatusUnknown

PhasePhase 3

Taking part206

StartedJan 2007

UpdatedAug 14, 2007

Conditions

Bipolar Disorder Mania

Where1

JDS Pharmaceuticals
New York, New York, United States

Clareo Health | Safety and Efficacy Study of Lithium in Bipolar Disorder